The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex multi-step synthetic process. Early routes focused on protein portion coupling, utilizing solid-phase https://elodiehrcu321748.blog2learn.com/88318264/creation-and-investigation-implementations-of-retatrutide